Bhoge et al. reported MUC1 positivity in 85.7% of GBC cases, compared to just 4.7% of chronic cholecystitis cases, supporting its utility in distinguishing malignant from inflammatory lesions [7]. Here, MUC1 is linked to Cholecystitis.